home / stock / rgls / rgls articles

RGLS Articles, Regulus Therapeutics Inc.

Stock Information
Company Name: Regulus Therapeutics Inc.
Stock Symbol: RGLS
Market: NASDAQ
Website: regulusrx.com
Menu
RGLS RGLS Quote RGLS Short RGLS News RGLS Articles RGLS Message Board
Get RGLS Alerts

News, Short Squeeze, Breakout and More Instantly...
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
What's Going On With Regulus Therapeutics Stock Monday? | Benzinga

Regulus Therapeutics, Inc. (NASDAQ:RGLS) shares were initially trading higher Monday before pulling back and turning negative after the company ann...

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial re...

Gold Down Over 1%; ClearOne Shares Spike Higher | Benzinga

U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up 0.74% to 39,057....
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. Asana reported quarterly losse...

Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet | Benzinga

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Tuesday. The Dow traded up 0.48% to 38,955.84 whil...

Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February | Benzinga

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Tuesday. Following the market opening Tuesday, the D...
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday? | Benzinga

Tuesday, Regulus Therapeutics Inc (NASDAQ:RGLS) released topline results from the second cohort of patients in its Phase 1b multiple-asce...

Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease | Benzinga

Regulus Therapeutics Inc (NASDAQ: RGLS) released topline results from the first cohort of patients in its Phase 1b Multiple-Ascending Dose (MA...

Next 10